Sort
261,768 grants matching “gene therapy”
Genetic Susceptibility to Pediatric Glioma inIndividuals and Diverse populations
$1,092,580Joseph Leo Wiemels · University Of Southern California · R01 · FY2020 · CA
Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome
$1,092,546Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
RNAi and Epigenetic Control of Higher-Order Chromatin Assembly
$1,092,546Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Epigenomics of T cells and innate immune cells in human asthma
$1,092,337Anjana Rao · La Jolla Institute For Immunology · R01 · FY2014 · HL
Nonhuman Primate Core
$1,092,245Shiu-Lok Hu · Fred Hutchinson Cancer Research Center · U19 · FY2014 · AI
Inhibition Of Renal Injury
$1,092,242Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Identifying Disease Variants for Familial Crohns Disease
$1,092,166Steven R Brant · Johns Hopkins University · R01 · FY2010 · DK
Host Targeted Therapy for Drug Resistant Salmonella and Francisella infection
$1,092,009Kristy M Ainslie · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Oral cleft prevention program
$1,091,722Jeffrey C Murray · University Of Iowa · U01 · FY2007 · DE
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy
$1,091,666David L Lampi Hermanson · B-Mogen Biotechnologies, Inc. · R44 · FY2019 · CA
MOLECULAR PATHOGENESIS OF CHROMOSOME 16 INVERSION IN HUMAN LEUKEMIA
$1,091,590Paul Liu · National Human Genome Research Institute · ZIA · FY2011 · HG
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
$1,091,444Matthew D Disney · Scripps Florida · P01 · FY2020 · NS
Virus host interactions in clinical samples
$1,091,396Joseph Ziegelbauer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Stanford Project 2
$1,091,369Calvin J Kuo · University Of California, San Francisco · U54 · FY2017 · CA
SRC ON PRIMARY AND METASTATIC TUMORS OF THE CNS
$1,091,364Duke University · P50 · FY2002 · NS
Clinical Analysis Of Disorders Of Hearing And Balance
$1,091,348Carmen Crowell Brewer · National Institute On Deafness And Other Communication Disorders · ZIA · FY2017 · DC
Neuronal and Progenitor/Stem Cell Function During Salivary Gland Development
$1,091,287Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2016 · DE
Clinical studies of skeletal diseases
$1,091,246Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE
Determinants of donor-specific T cell tolerance in kidney transplantation in non-sensitized recipients
$1,091,227Xunrong Luo · Duke University · U19 · FY2023 · AI
Single and Double AAV Somatic Gene Amelioration of Mouse Models of LAMA2 Related Dystrophy
$1,091,199Peter D Yurchenco · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AR
Signaling in the retina and retinal pigment epithelium
$1,091,042Thomas Redmond · National Eye Institute · ZIA · FY2014 · EY
Molecular Pathogenesis of Basal-like Breast Cancer
$1,090,942Richard J Baer · Columbia University Health Sciences · P01 · FY2013 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER
$1,090,923Thomas Jefferson University · P01 · FY2000 · CA
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2023 · AI
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2022 · AI